Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Osteoporosis × Denosumab × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Genitourinary 1 Endocrine 1 Breast 1

Conditions

Thyroid Cancer Metastatic 1 Osteoporosis 1 Multiple Endocrine Neoplasia Type 1 1 Bone Diseases, Metabolic 1

Interventions

X-Rays 1 Vitamin D 1 Observation 1 Denosumab 1 Calcium 1 Biological Products 1 Adrenalectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00980174 2018-10-17

Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis

Amgen

Phase 3 Completed

242 enrolled 19 charts

Bone Diseases, Metabolic, Osteoporosis, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡